Low‐dose immune tolerance induction alone or with immunosuppressants according to prognostic risk factors in Chinese children with hemophilia A inhibitors

BACKGROUND: In developing countries, children with hemophilia A (HA) with high‐titer inhibitor and poor immune tolerance induction (ITI) prognostic risk(s) cannot afford the recommended high‐ or intermediate‐dose ITI. OBJECTIVES: To determine the efficacy of low‐dose ITI (plasma‐derived factor VIII...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Res Pract Thromb Haemost
Autores principales: Li, Zekun, Chen, Zhenping, Liu, Guoqing, Cheng, Xiaoling, Yao, Wanru, Huang, Kun, Li, Gang, Zhen, Yingzi, Wu, Xinyi, Cai, Siyu, Poon, Man‐Chiu, Wu, Runhui
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8279128/
https://ncbi.nlm.nih.gov/pubmed/34278191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12562
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares